BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17653245)

  • 1. Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma.
    Yockman JW; Kim WJ; Chang CW; Kim SW
    Gene Ther; 2007 Oct; 14(19):1399-405. PubMed ID: 17653245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice.
    Kim WJ; Yockman JW; Jeong JH; Christensen LV; Lee M; Kim YH; Kim SW
    J Control Release; 2006 Sep; 114(3):381-8. PubMed ID: 16884805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
    Ichikura H; Eto M; Ueno H; Harada M; Takayama K; Tokuda N; Tatsugami K; Naito S
    Oncol Rep; 2006 May; 15(5):1333-7. PubMed ID: 16596207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
    Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
    Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
    Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
    Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand expression in metastatic renal cell carcinoma during interleukin-2 based immunotherapy: no in vivo effect of Fas ligand tumor counterattack.
    Donskov F; von der Maase H; Marcussen N; Hamilton-Dutoit S; Madsen HH; Jensen JJ; Hokland M
    Clin Cancer Res; 2004 Dec; 10(23):7911-6. PubMed ID: 15585624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.
    Saffran DC; Horton HM; Yankauckas MA; Anderson D; Barnhart KM; Abai AM; Hobart P; Manthorpe M; Norman JA; Parker SE
    Cancer Gene Ther; 1998; 5(5):321-30. PubMed ID: 9824052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.
    Dezso B; Haas GP; Hamzavi F; Kim S; Montecillo EJ; Benson PD; Pontes JE; Maughan RL; Hillman GG
    Clin Cancer Res; 1996 Sep; 2(9):1543-52. PubMed ID: 9816331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
    Galanis E; Burch PA; Richardson RL; Lewis B; Pitot HC; Frytak S; Spier C; Akporiaye ET; Peethambaram PP; Kaur JS; Okuno SH; Unni KK; Rubin J
    Cancer; 2004 Dec; 101(11):2557-66. PubMed ID: 15517589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy enhances the therapeutic effect of immunotherapy on pulmonary metastases in a murine renal adenocarcinoma model.
    Chakrabarty A; Hillman GG; Maughan RL; Ali E; Pontes JE; Haas GP
    In Vivo; 1994; 8(1):25-31. PubMed ID: 8054507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor infiltrating dendritic cells predict treatment response to immmunotherapy in patients with metastatic renal cell carcinoma.
    Kobayashi M; Suzuki K; Yashi M; Yuzawa M; Takayashiki N; Morita T
    Anticancer Res; 2007; 27(2):1137-41. PubMed ID: 17465253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil.
    Bishop JS; Thull NM; Matar M; Quezada A; Munger WE; Batten TL; Muller S; Pericle F
    Cancer Gene Ther; 2000 Aug; 7(8):1165-71. PubMed ID: 10975677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
    Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
    Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment.
    Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
    J Control Release; 2005 Jan; 101(1-3):273-85. PubMed ID: 15588911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.
    Moffatt S; Wiehle S; Cristiano RJ
    Gene Ther; 2006 Nov; 13(21):1512-23. PubMed ID: 16763664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
    Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
    J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
    Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
    Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.